Pharm prime vendor fleet
Ended Awarded
- Contract number
- SPE2DU25F0J80
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,284
Award facts
- Contract value 100% obligated
- $7,284.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,284.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This firm fixed-price delivery order, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, was awarded without a set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. The delivery order falls under the broader Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion DLA acquisition strategy that establishes multiple regional prime vendor contractors to supply pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group holds a single-award indefinite delivery contract (IDC) under the PPV-G GEN V initiative with a ceiling value of $499,999,999 and completion date of December 31, 2036. Through this contract vehicle, the company supplies a comprehensive range of pharmaceuticals including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and medical consumables to support recurring medical supply needs across the military healthcare system. The vendor's product portfolio encompasses oncology treatments, immunosuppressants, emergency medications, surgical products, and routine pharmaceuticals, positioning DMS Pharmaceutical Group as a critical supplier within the federal pharmaceutical supply chain with no identified subcontractors.
Quick answers
Who was awarded contract SPE2DU25F0J80?
SPE2DU25F0J80 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DU25F0J80 worth?
The government has obligated $7,284 on SPE2DU25F0J80.
Is contract SPE2DU25F0J80 an order under another contract?
Yes. SPE2DU25F0J80 is a delivery order under SPE2DU25D9811, an indefinite delivery contract.
Was contract SPE2DU25F0J80 competed?
The extent of competition for SPE2DU25F0J80 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award